Feature

With the corporate healthcare cash plan market going from strength to strength, Johanna Gornitzki discovers a sector filled with new business opportunities for advisers

Multiple sclerosis can have severe implications for individual protection assurance, says Lisa Allcock

Damaging allegations of mis-selling occur frequently in the critical illness and income protection markets. Rona Doyle explains how to avoid the pitfalls

Despite being a highly valued employee benefit, the take-up of corporate private healthcare schemes remains very low. Peter Madigan reports

Tele-underwriting can reduce the time required to process protection applications and in some cases, eradicate the need for additional medical evidence, says Gerry Warner

Assessing the risk of congenital heart disease can prove problematic. Wendy Hickman looks at the implications for protection cover

From an insurance perspective the implications on the underwriting process largely depend on the und...

Under Financial Services Authority regulation, the demands and needs statement can prove a useful sales tool. Nick Kirwan explains

• In the UK there are about 4,600 babies born with congenital heart disease each year. • The progn...

Equity release is becoming increasingly popular, but brokers need to make sure borrowers understand what they are dealing with, say Jackie Bennet and Bob Wright